Related Blog Posts
SABCS: Dr. Dennis Slamon Continues Research with Herceptin
13 hours ago ago from About.com Breast Cancer
Dr. Dennis Slamon Photo Courtesy SABCS/Todd Buchanan 2009 Even if you haven't dealt with HER2 positive breast cancer, you've probably heard of the drug Herceptin or the movie "Living Proof" about Dr. Dennis Slamon and his work with breast cancer patients. Dr. Slamon is one of the rock stars of breast cancer research. Herceptin, a targeted biological therapy, was developed by Dr. Slamon and a team of researchers, and was tested on ...
Related contentChemo With Herceptin May Be Best for Some Breast Cancers (HealthDay)
14 hours ago ago from Drugs and Diseases
HealthDay - SATURDAY, Dec. 12 (HealthDay News) New research suggests that certain breast cancer patients who take the drug Herceptin during chemotherapy, instead of taking it afterward, fare better, leading one of the study authors to say patients should routinely take the drug with chemo. Read More..
Related contentChemo With Herceptin May Be Best for Some Breast Cancers
21 hours ago ago from Free Doctor Advise
New research suggests that certain breast cancer patients who take the drug Herceptin during chemotherapy, instead of taking it afterward, fare better, leading one of the study authors to say patients should routinely take the drug with chemo. See the original post: Chemo With Herceptin May Be Best for Some Breast Cancers
Related contentTweaks to Breast Cancer Treatments Boost Outcomes
21 hours ago ago from Free Doctor Advise
With a growing array of choices for breast cancer treatment, researchers are now trying to pinpoint the best combination of therapies or the best order in which to give cancer drugs to patients. Link: Tweaks to Breast Cancer Treatments Boost Outcomes
Related contentFile Hurricane - Register An Account
17 hours ago ago from File Hurricane - Upload & Share Pics and Videos for Free!
Login | Register | Help home upload tags rss username: password: confirm: email: FileHurricane currently hosts 6218 media files with 6200 unique tags. | Site ...
Related contentRelated News
FDA says OSI drug effective against lung cancer
19 hours ago ago from U.S. News
FDA says OSI drug effective against lung cancer WASHINGTON (AP) -- Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy. The Food and Drug Administration on Monday posted its review of the drug for a new use against lung cancer. OSI wants the FDA to approve Tarceva as a maintenance therapy, or a drug designed to stop cancer from ...
Related contentPromising new developments on the breast cancer front
14 hours ago ago from DailyFinance
The San Antonio Breast Cancer Symposium , held Dec. 9-13, brought mostly good news for breast cancer patients and drugmakers. And that's a welcome development: Aside from non-melanoma skin cancer, breast cancer is the most common form of cancer in women and the second-leading cause of cancer death in women. Estimates for 2009 put the number of new cases at over 192,000 women and nearly 2,000 men, with over 40,000 deaths in women and 440 in ...
Related contentRelated Videos
